The Corporate Human Rights Benchmark (CHRB) was launched in 2013 as a non for profit multi-stakeholder initiative, drawing on investor, business and human rights and benchmarking expertise from the following organisations:
- APG Asset Management APG
- Aviva Investors
- Business & Human Rights Resource Centre
- EIRIS Foundation
- Institute for Human Rights and Business (IHRB)
- Nordea Wealth Management.
In 2019, the CHRB became a part of the World Benchmarking Alliance. Below are the reports, methodologies, scorecards and announcements published by the Corporate Human Rights Benchmark prior to this integration.
2019 Corporate Human Rights Benchmark Key Findings Report
This report provides an overview of the 2019 Corporate Human Rights Benchmark, which assessed 195 companies in the agricultural products, apparel, extractives and ICT manufacturing sectors.Download report
2018 Corporate Human Rights Benchmark Key Findings Report
This report lays out the results of the 2018 Corporate Human Rights Benchmark of 101 companies in the apparel, agricultural products and extractives sectors. It breaks down the results by measurement theme and outlines specific calls to action for businesses, investors, governments and civil society.Download report
2017 Corporate Human Rights Benchmark Key Findings Report
This report summarises the results of the first ever Corporate Human Rights Benchmark, which assessed 106 companies across the agricultural products, apparel and extractives industries.Download report
Core UNGP Indicators
This document sets out a stand-alone CHRB methodology to assess how companies are approaching their responsibilities to respect human rights through the implementation of the UN Guiding Principles on Business and Human Rights (UNGPs).
The full CHRB Methodology covers six Themes, is grounded in the UNGPs and covers over 80 indicators. To develop this core indicator list, CHRB focused on the non-industry specific indicators that dealt with three key areas of the UNGPs; high level commitments, human rights due diligence and access to remedy.